Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2020

01-02-2020 | Opioids | Original Research

Poorer Physical and Mental Health Status Are Associated with Subsequent Opioid Prescriptions: a U.S. National Study

Authors: Anthony Jerant, MD, Alicia Agnoli, MD, MPH, MHS, Peter Franks, MD

Published in: Journal of General Internal Medicine | Issue 2/2020

Login to get access

Abstract

Background

How physical and mental health status relate to receipt of opioid prescription remains unclear, creating uncertainty in minimizing opioid harms while avoiding pain under-treatment.

Objective

To examine the associations of physical and mental health status with subsequent opioid prescriptions.

Design

Observational study of 2005–2015 United States (U.S.) Medical Expenditure Panel Survey data.

Participants

Adult respondents (N = 78,563) participating for 2 years. The analyses focused on respondents reporting no opioid prescriptions in year 1 (N = 65,249).

Main Measures

In the primary analysis, a negative binomial regression yielding adjusted incidence rate ratios (IRRs), the dependent variable was the number of opioid prescriptions in year 2. In two secondary analyses, both logistic regressions yielding adjusted odds ratios (ORs), the dependent variables were receipt of any opioid prescription (versus none) and receipt of ≥ 6 opioid prescriptions (versus 0–5) in year 2. The key independent variables in all analyses were the SF-12 Physical and Mental Component Summary scores (PCS-12 and MCS-12, respectively; higher scores = better health status). All models adjusted for socio-demographics, health-related variables, and year.

Key Results

Primary analysis. With each 10-point decrement in year 1 PCS-12 or MCS-12 score, there were more opioid prescriptions received in year 2 (adjusted IRRs [95% CIs] 1.45 [1.39–1.52] and 1.22 [1.16–1.27], respectively). Secondary analyses. With each 10-point decrement in year 1 PCS-12 or MCS-12 score, there were higher odds in year 2 both of receiving any opioid prescription (adjusted ORs 1.23 [1.19–1.28] and 1.11 [1.08–1.15], respectively) and of receiving ≥ 6 opioid prescriptions (adjusted ORs 1.96 [1.75–2.17] and 1.37 [1.23–1.54], respectively).

Conclusions

In a nationally representative U.S. sample, both poorer physical and mental health status independently predicted receiving more opioid prescriptions received in a subsequent year, as well as receiving ≥ 6 prescriptions during the year. Our findings may contribute to a more nuanced picture of the drivers of opioid prescription.
Literature
1.
go back to reference Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39:6-12.CrossRef Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39:6-12.CrossRef
2.
go back to reference Alexander LM, Keahey D, Dixon K. Opioid use disorder: a public health emergency. JAAPA. 2018;31:47-52.CrossRef Alexander LM, Keahey D, Dixon K. Opioid use disorder: a public health emergency. JAAPA. 2018;31:47-52.CrossRef
4.
go back to reference The opioid crisis in the USA: a public health emergency. Lancet. 2017;390:2016. The opioid crisis in the USA: a public health emergency. Lancet. 2017;390:2016.
5.
go back to reference Dowell D, Haegerich TM, Chou R. CDC Guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315:1624-45.CrossRef Dowell D, Haegerich TM, Chou R. CDC Guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315:1624-45.CrossRef
6.
go back to reference Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017;20:S3-S92.CrossRef Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017;20:S3-S92.CrossRef
7.
go back to reference Karafin MS, Singavi A, Hussain J, et al. Predictive factors of daily opioid use and quality of life in adults with sickle cell disease. Hematology. 2018;23:856-63.CrossRef Karafin MS, Singavi A, Hussain J, et al. Predictive factors of daily opioid use and quality of life in adults with sickle cell disease. Hematology. 2018;23:856-63.CrossRef
8.
go back to reference Anderson A, Click B, Ramos-Rivers C, et al. The association between sustained poor quality of life and future opioid use in inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:1380-8.CrossRef Anderson A, Click B, Ramos-Rivers C, et al. The association between sustained poor quality of life and future opioid use in inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:1380-8.CrossRef
9.
go back to reference Dillie KS, Fleming MF, Mundt MP, et al. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med. 2008;21:108-17.CrossRef Dillie KS, Fleming MF, Mundt MP, et al. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med. 2008;21:108-17.CrossRef
10.
go back to reference Davis MA, Lin LA, Liu H, Sites BD. Prescription opioid use among adults with mental health disorders in the United States. J Am Board Fam Med. 2017;30:407-17.CrossRef Davis MA, Lin LA, Liu H, Sites BD. Prescription opioid use among adults with mental health disorders in the United States. J Am Board Fam Med. 2017;30:407-17.CrossRef
11.
go back to reference Torrance N, Lawson KD, Afolabi E, et al. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter? Pain. 2014;155:1996-2004.CrossRef Torrance N, Lawson KD, Afolabi E, et al. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter? Pain. 2014;155:1996-2004.CrossRef
12.
go back to reference Bao Y, Sturm R, Croghan TW. A national study of the effect of chronic pain on the use of health care by depressed persons. Psychiatr Serv. 2003;54:693-7.CrossRef Bao Y, Sturm R, Croghan TW. A national study of the effect of chronic pain on the use of health care by depressed persons. Psychiatr Serv. 2003;54:693-7.CrossRef
13.
go back to reference Linton SJ, Shaw WS. Impact of psychological factors in the experience of pain. Phys Ther. 2011;91:700-11.CrossRef Linton SJ, Shaw WS. Impact of psychological factors in the experience of pain. Phys Ther. 2011;91:700-11.CrossRef
14.
go back to reference Turk DC, Okifuji A. What factors affect physicians’ decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain. 1997;13:330-6.CrossRef Turk DC, Okifuji A. What factors affect physicians’ decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain. 1997;13:330-6.CrossRef
15.
go back to reference Patients with mental disorders get half of all opioid prescriptions. Kaiser Health News. June 26, 2017. Patients with mental disorders get half of all opioid prescriptions. Kaiser Health News. June 26, 2017.
16.
go back to reference Goesling J, Henry MJ, Moser SE, et al. Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain. 2015;16:844-51.CrossRef Goesling J, Henry MJ, Moser SE, et al. Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain. 2015;16:844-51.CrossRef
17.
go back to reference Halbert BT, Davis RB, Wee CC. Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain. 2016;157:2452-7.CrossRef Halbert BT, Davis RB, Wee CC. Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain. 2016;157:2452-7.CrossRef
18.
go back to reference Sullivan MD, Edlund MJ, Zhang L, et al. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087-93.CrossRef Sullivan MD, Edlund MJ, Zhang L, et al. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087-93.CrossRef
19.
go back to reference Weinberger AH, Gbedemah M, Martinez AM, et al. Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychol Med. 2018;48:1308-15.CrossRef Weinberger AH, Gbedemah M, Martinez AM, et al. Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychol Med. 2018;48:1308-15.CrossRef
20.
go back to reference Mojtabai R, Jorm AF. Trends in psychological distress, depressive episodes and mental health treatment-seeking in the United States: 2001-2012. J Affect Disord. 2015;174:556-61.CrossRef Mojtabai R, Jorm AF. Trends in psychological distress, depressive episodes and mental health treatment-seeking in the United States: 2001-2012. J Affect Disord. 2015;174:556-61.CrossRef
21.
go back to reference Wittayanukorn S, Qian J, Hansen RA. Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010. Gen Hosp Psychiatry. 2014;36:330-6.CrossRef Wittayanukorn S, Qian J, Hansen RA. Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010. Gen Hosp Psychiatry. 2014;36:330-6.CrossRef
22.
go back to reference Carvalho AS, Martins Pereira S, Jacomo A, et al. Ethical decision making in pain management: a conceptual framework. J Pain Res. 2018;11:967-76.CrossRef Carvalho AS, Martins Pereira S, Jacomo A, et al. Ethical decision making in pain management: a conceptual framework. J Pain Res. 2018;11:967-76.CrossRef
23.
go back to reference Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32:4149-54.CrossRef Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32:4149-54.CrossRef
24.
go back to reference Jukic M, Puljak L. Legal and ethical aspects of pain management. Acta Med Acad. 2018;47:18-26.PubMed Jukic M, Puljak L. Legal and ethical aspects of pain management. Acta Med Acad. 2018;47:18-26.PubMed
25.
go back to reference Seers T, Derry S, Seers K, et al. Professionals underestimate patients’ pain: a comprehensive review. Pain. 2018;159:811-8.CrossRef Seers T, Derry S, Seers K, et al. Professionals underestimate patients’ pain: a comprehensive review. Pain. 2018;159:811-8.CrossRef
26.
go back to reference Kroenke K, Cheville A. Management of chronic pain in the aftermath of the opioid backlash. JAMA. 2017;317:2365-6.CrossRef Kroenke K, Cheville A. Management of chronic pain in the aftermath of the opioid backlash. JAMA. 2017;317:2365-6.CrossRef
27.
go back to reference Fishman S, Berger L. The War on Pain. New York, NY: Harper Perennial; 2001. Fishman S, Berger L. The War on Pain. New York, NY: Harper Perennial; 2001.
28.
go back to reference Dineen KK, DuBois JM. Between a rock and a hard place: can physicians prescribe opioid to treat pain adequately while avoiding legal sanction? Am J Law Med. 2016;42:7-52.CrossRef Dineen KK, DuBois JM. Between a rock and a hard place: can physicians prescribe opioid to treat pain adequately while avoiding legal sanction? Am J Law Med. 2016;42:7-52.CrossRef
32.
go back to reference Ware J Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-33.CrossRef Ware J Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-33.CrossRef
33.
go back to reference Nosyk B, Sun H, Guh DP, et al. The quality of eight health status measures were compared for chronic opioid dependence. J Clin Epidemiol. 2010;63:1132-44.CrossRef Nosyk B, Sun H, Guh DP, et al. The quality of eight health status measures were compared for chronic opioid dependence. J Clin Epidemiol. 2010;63:1132-44.CrossRef
34.
go back to reference Payne EH, Hardin JW, Egede LE, et al. Approaches for dealing with various sources of overdispersion in modeling count data: scale adjustment versus modeling. Stat Methods Med Res. 2017;26:1802-23.CrossRef Payne EH, Hardin JW, Egede LE, et al. Approaches for dealing with various sources of overdispersion in modeling count data: scale adjustment versus modeling. Stat Methods Med Res. 2017;26:1802-23.CrossRef
35.
go back to reference Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15:141-55.CrossRef Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15:141-55.CrossRef
36.
go back to reference Diaz-Arribas MJ, Fernandez-Serrano M, Royuela A, et al. Minimal clinically important difference in quality of life for patients with low back pain. Spine. 2017;42:1908-16.CrossRef Diaz-Arribas MJ, Fernandez-Serrano M, Royuela A, et al. Minimal clinically important difference in quality of life for patients with low back pain. Spine. 2017;42:1908-16.CrossRef
37.
go back to reference Jayadevappa R, Cook R, Chhatre S. Minimal important difference to infer changes in health-related quality of life - a systematic review. J Clin Epidemiol. 2017;89:188-98.CrossRef Jayadevappa R, Cook R, Chhatre S. Minimal important difference to infer changes in health-related quality of life - a systematic review. J Clin Epidemiol. 2017;89:188-98.CrossRef
38.
go back to reference Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care. 2000;38:1141-50.CrossRef Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care. 2000;38:1141-50.CrossRef
39.
go back to reference Vilagut G, Forero CG, Pinto-Meza A, et al. The mental component of the short-form 12 health survey (SF-12) as a measure of depressive disorders in the general population: results with three alternative scoring methods. Value Health. 2013;16:564-73CrossRef Vilagut G, Forero CG, Pinto-Meza A, et al. The mental component of the short-form 12 health survey (SF-12) as a measure of depressive disorders in the general population: results with three alternative scoring methods. Value Health. 2013;16:564-73CrossRef
40.
go back to reference Mojtabai R. National trends in long-term use of prescription opioids. Pharmacoepidemiol Drug Saf. 2018;27:526-34.CrossRef Mojtabai R. National trends in long-term use of prescription opioids. Pharmacoepidemiol Drug Saf. 2018;27:526-34.CrossRef
41.
go back to reference Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790.CrossRef Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790.CrossRef
Metadata
Title
Poorer Physical and Mental Health Status Are Associated with Subsequent Opioid Prescriptions: a U.S. National Study
Authors
Anthony Jerant, MD
Alicia Agnoli, MD, MPH, MHS
Peter Franks, MD
Publication date
01-02-2020
Publisher
Springer US
Keywords
Opioids
Opioids
Published in
Journal of General Internal Medicine / Issue 2/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05401-z

Other articles of this Issue 2/2020

Journal of General Internal Medicine 2/2020 Go to the issue